New pathogenetic insights into pseudoexfoliation syndrome/glaucoma: Therapeutically relevant?;Neue pathogenetische Erkenntnisse zum Pseudoexfoliations-Syndrom/Glaukom: Therapeutisch relevant?

Ophthalmologe

Volumn 109, Issue 10, 2012, Pages 944-951

  Schlotzer Schrehardt U ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

Elastic fibers; Extracellular matrix; LOXL1; PEX; Pseudoexfoliation syndrome

Indexed keywords

MATRIX METALLOPROTEINASE; OLR1 PROTEIN, HUMAN; OXIDIZED LOW DENSITY LIPOPROTEIN RECEPTOR 1; TISSUE INHIBITOR OF METALLOPROTEINASE; TRANSFORMING GROWTH FACTOR BETA1;

COMORBIDITY; ELASTIC TISSUE; EXTRACELLULAR MATRIX; FLUORESCENCE MICROSCOPY; GENETIC PREDISPOSITION; GENETIC VARIABILITY; GENETICS; GONIOSCOPY; HUMAN; INTRAOCULAR PRESSURE; OPTIC NERVE; OXIDATIVE STRESS; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PSEUDOEXFOLIATION; REVIEW; RISK FACTOR; SCANNING ELECTRON MICROSCOPY; TRABECULAR MESHWORK;

COMORBIDITY; ELASTIC TISSUE; EXFOLIATION SYNDROME; EXTRACELLULAR MATRIX; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GONIOSCOPY; HUMANS; INTRAOCULAR PRESSURE; MATRIX METALLOPROTEINASES; MICROSCOPY, ELECTRON, SCANNING; MICROSCOPY, FLUORESCENCE; OPTIC NERVE; OXIDATIVE STRESS; RISK FACTORS; SCAVENGER RECEPTORS, CLASS E; TISSUE INHIBITOR OF METALLOPROTEINASES; TRABECULAR MESHWORK; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84867899178     PISSN: 0941293X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00347-012-2531-1     Document Type: Article

References (36)

1. Ritch R, Schlötzer-Schrehardt U (2001) Exfoliation syndrome. Surv Ophthalmol 45: 265-315.
2. Schlötzer-Schrehardt U, Naumann GOH (2006) Perspective: ocular and systemic pseudoexfoliation syndrome. Am J Ophthalmol 141: 921-937.
3. Ritch R (1994) Exfoliation syndrome: the most common identifiable cause of open-angle glaucoma. J Glaucoma 3: 176-178.
4. Naumann GOH, Schlötzer-Schrehardt U, Küchle M (1998) Pseudoexfoliation syndrome for the comprehensive ophthalmologist: Intraocular and systemic manifestations. Ophthalmology 105: 951-968.
5. Schumacher S, Schlötzer-Schrehardt U, Martus P et al (2001) Pseudoexfoliation syndrome and aneurysms of the abdominal aorta. Lancet 357: 359-360.
6. Mitchell P, Wang JJ, Smith W (1997) Association of pseudoexfoliation syndrome with increased vascular risk. Am J Ophthalmol 124: 685-687.
7. Ritland JS, Egge K, Lydersen S et al (2004) Exfoliative glaucoma and primary open-angle glaucoma: associations with death causes and comorbidity. Acta Ophthalmol Scand 82: 401-404.
8. Roedl JB, Bleich S, Reulbach U et al (2007) Vitamin deficiency and hyperhomocysteinemia in pseudoexfoliation glaucoma. J Neural Transm 114: 571-575.
9. Ovodenko B, Rostagno A, Neubert TA et al (2007) Proteomic analysis of exfoliation deposits. Invest Ophthalmol Vis Sci 48: 1447-1457.
10. Zenkel M, Kruse FE, Naumann GOH, Schlötzer-Schrehardt U (2007) Impaired cytoprotective mechanisms in eyes with pseudoexfoliation syndrome/glaucoma. Invest Ophthalmol Vis Sci 48: 5558-5566.
11. Zenkel M, Lewczuk P, Jünemann A et al (2010) Pro-inflammatory cytokines are involved in initiation of the abnormal matrix process in pseudoexfoliation syndrome/glaucoma. Am J Pathol 176: 2868-2879.
12. Schlötzer-Schrehardt U (2010) Oxidativer Stress beim Pseudoexfoliationsglaukom. Klin Monatsbl Augenheilkd 227: 108-113.
13. Arnarsson A, Damji KF, Sasaki H et al (2009) Pseudoexfoliation in the Reykjavik Eye Study: five-year incidence and changes in related ophthalmologic variables. Am J Ophthalmol 148: 291-297.
14. Johnson TV, Fan S, Camras CB, Toris CB (2008) Aqueous humor dynamics in exfoliation syndrome. Arch Ophthalmol 126: 914-920.
15. Schlötzer-Schrehardt U, Naumann GOH (1995) Trabecular meshwork in pseudoexfoliation syndrome with and without open-angle glaucoma. A morphometric, ultrastructural study. Invest Ophthalmol Vis Sci 36: 1750-1764.
16. Gottanka J, Flügel-Koch C, Martus P (1997) Correlation of pseudoexfoliative material and optic nerve damage in pseudoexfoliation syndrome. Invest Ophthalmol Vis Sci 38: 2435-2446.
17. Thorleifsson G, Magnusson KP, Sulem P et al (2007) Common sequence variants in the LOXL1 gene confer susceptibility to exfoliation glaucoma. Science 317: 1397-1400.
18. Pasutto F, Krumbiegel M, Mardin CY et al (2008) Association of LOXL1 common sequence variants in German and Italian patients with pseudoexfoliation syndrome and pseudoexfoliation glaucoma. Invest Ophthalmol Vis Sci 49: 1459-1463.
19. Chen H, Chen LJ, Zhang M et al (2010) Ethnicity-based subgroup meta-analysis of the association of LOXL1 polymorphisms with glaucoma. Mol Vis 16: 167-177.
20. Hindorff LA, Sethupathy P, Junkins HA et al (2009) Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc Natl Acad Sci USA 106: 9362-9367.
21. Challa P (2009) Genetics of pseudoexfoliation syndrome. Curr Opin Ophthalmol 20: 88-91.
22. Schlötzer-Schrehardt U (2011) Genetics and genomics of pseudoexfoliation syndrome/-glaucoma. Middle East Afr J Ophthalmol 18: 30-36.
23. Zenkel M, Kruse FE, Jünemann AG et al (2006) Clusterin deficiency in eyes with pseudoexfoliation syndrome may be implicated in the aggregation and deposition of pseudoexfoliative material. Invest Ophthalmol Vis Sci 47: 1982-1990.
24. Csiszar K (2001) Lysyl oxidases: a novel multifunctional amine oxidase family. Prog Nucleic Acid Res Mol Biol 70: 1-32.
25. Rodriguez C, Rodriguez-Sinovas A, Martinez-Gonzalez J (2008) Lysyl oxidase as a potential therapeutic target. Drug News Perspect 21: 218-224.
26. Schlötzer-Schrehardt U, Pasutto F, Sommer P et al (2008) Genotype-correlated expression of lysyl oxidase-like 1 in ocular tissues of patients with pseudoexfoliation syndrome/glaucoma and normal patients. Am J Pathol 173: 1724-1735.
27. Schlötzer-Schrehardt U (2009) Molecular pathology of pseudoexfoliation syndrome/glaucoma: new insights from LOXL1 gene associations. Exp Eye Res 88: 776-785.
28. Zenkel M, Krysta A, Pasutto F et al (2011) Regulation of lysyl oxidase-like 1 (LOXL1) and elastin-related genes by pathogenic factors associated with pseudoexfoliation syndrome. Invest Ophthalmol Vis Sci 52: 8488-8495.
29. Burgoyne CF, Downs JC, Bellezza AJ et al (2005) The optic nerve head as a biomechanical structure: a new paradigm for understanding the role of IOP-related stress and strain in the pathophysiology of glaucomatous optic nerve head damage. Progr Ret Eye Res 24: 39-73.
30. Schlötzer-Schrehardt U, Hammer CM, Krysta AW et al (2012) LOXL1 deficiency in the lamina cribrosa as candidate susceptibility factor for a pseudoexfoliation-specific risk of glaucoma development. Ophthalmology 119: 1832-1843.
31. Braunsmann C, Hammer CM, Rheinlaender J et al (2012) Evaluation of lamina cribrosa and peripapillary sclera stiffness in pseudoexfoliation and normal eyes by atomic force microscopy. Invest Ophthalmol Vis Sci 53: 2960-2967.
32. Koz OG, Turkcu MF, Yarangumeli A et al (2009) Normotensive glaucoma and risk factors in normotensive eyes with pseudoexfoliation syndrome. J Glaucoma 18: 684-688.
33. Grodum K, Heijl A, Bengtsson B (2005) Risk of glaucoma in ocular hypertension with and without pseudoexfoliation. Ophthalmology 112: 386-390.
34. Topouzis F, Harris A, Wilson MR et al (2009) Increased likelihood of glaucoma at the same intraocular pressure in subjects with pseudoexfoliation: the Thessaloniki Eye Study. Am J Ophthalmol 148: 606-613.
35. Heijl A, Bengtsson B, Hyman L et al (2009) Natural history of open-angle glaucoma. Ophthalmology 116: 2271-2276.
36. Liu X et al (2004) Elastic fiber homeostasis requires lysyl oxidase-like 1 protein. Nat Genet 36: 178-182.